Grape King Bio Ltd (TPE: 1707)
Taiwan
· Delayed Price · Currency is TWD
147.00
0.00 (0.00%)
Jan 3, 2025, 1:30 PM CST
Grape King Bio Revenue
Grape King Bio had revenue of 2.90B TWD in the quarter ending September 30, 2024, with 13.66% growth. This brings the company's revenue in the last twelve months to 11.21B, up 6.12% year-over-year. In the year 2023, Grape King Bio had annual revenue of 10.64B with 2.35% growth.
Revenue (ttm)
11.21B
Revenue Growth
+6.12%
P/S Ratio
1.95
Revenue / Employee
22.37M
Employees
501
Market Cap
21.85B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 10.64B | 244.23M | 2.35% |
Dec 31, 2022 | 10.39B | 592.99M | 6.05% |
Dec 31, 2021 | 9.80B | 630.05M | 6.87% |
Dec 31, 2020 | 9.17B | -70.88M | -0.77% |
Dec 31, 2019 | 9.24B | 55.75M | 0.61% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PharmaEssentia | 8.32B |
Caliway Biopharmaceuticals | 49.98M |
Bora Pharmaceuticals Co., LTD. | 16.71B |
Lotus Pharmaceutical | 17.59B |
Oneness Biotech | 112.20M |
Lumosa Therapeutics | 37.82M |
Polaris Group | 75.65M |
Center Laboratories | 1.57B |